Picture of Tilray Brands logo

TLRY — Tilray Brands News Story

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Tilray Q4 revenue falls, net loss widens to $1.27 bln

Overview

Q4 revenue declines to $224.5 mln, impacted by strategic decisions

International cannabis revenue up 71% in Q4

Company reduces total debt repayments of ~$100 mln to date, strengthening balance sheet

Outlook

Tilray expects FY 2026 adjusted EBITDA of $62 mln to $72 mln

Company anticipates growth in cannabis, beverage, and wellness sectors

Tilray plans to enhance global supply chain in 2026

Company sees growth opportunities in Europe and emerging markets

Result Drivers

INTERNATIONAL GROWTH - International cannabis revenue increased by 71% in Q4, driven by strategic market expansions

BEVERAGE STRATEGY - Beverage revenue impacted project 420 and national SKU rationalization across co's recently acquired craft beverage brands

Key Details

MetricBeat/MissActualConsensus Estimate
Q4 Revenue$224.54 mln
Q4 Adjusted EPS$0.02
Q4 Net Income-$1.27 bln
Q4 Basic EPS-$1.3
Analyst Coverage The one available analyst rating on the shares is "hold" Wall Street's median 12-month price target for Tilray Brands Inc is C$1.36, about 30.9% above its July 25 closing price of C$0.94 Press Release: ID:nGNX30KSHh (This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Tilray Brands

See all news